O
rthopedic injuries constitute the majority of wounds sustained by US soldiers in recent conflicts. [1] [2] [3] [4] Typically, these include a large percentage of fractures, the majority of which are open, complex injuries prone to infection, and other complications. 5, 6 Further complicating therapy is the likelihood of infection with resistant gram-negative organisms as reported during Operations Iraqi Freedom and Enduring Freedom (OIF/OEF). [7] [8] [9] Given the paucity of active antimicrobial agents, the complicated nature of the injuries, and the typical presence of orthopedic devices, it is expected that a significant number of these infections will fail therapy or recur after initial improvement. Although recurrence of osteomyelitis with the original pathogen is well described, recurrences with a different organism, and without an obvious source of reinfection, are less commonly reported. 10 -12 Growing evidence documents the widespread presence of Acinetobacter baumannii-calcoaceticus complex (Abc) in infections related to OIF/OEF, although the virulence of this organism in a variety of clinical settings has been called into question. 7, 13 A recent publication by Johnson et al. documents the replacement of multidrug resistant gramnegative rods (MDR-GNR) with staphylococci at the time of recurrence of osteomyelitis of the tibia, but whether this is true for other sites of infection is not known.
14 It is also unknown in the context of combat-related osteomyelitis which risk factors predict relapse or recurrence, and whether these MDR-GNR are directly responsible for recurrent osteomyelitis, or whether the microbiology changes over time. The goal of this study was to describe the demographics, microbiology, and outcomes of osteomyelitis occurring in wounded service members treated at our facility, and to analyze the role of MDR-GNR in recurrences.
METHODS
This study was a retrospective chart review of OIF/OEF patients cared for at Brooke Army Medical Center, Fort Sam Houston, TX, between February 2003 and August 2006, and was approved by the institutional review board. Electronic medical records were used to identify all patients who had been redeployed from OIF/OEF with a diagnosis of osteomyelitis given on physician admission, discharge, or progress 
RESULTS
During the study period there were 2,854 admissions among OIF/OEF veterans, of which 664 were admitted to the orthopedic service. There were a total of 103 initial admissions with a diagnosis of osteomyelitis, among 101 individual patients ( Table 1) . Duration of follow-up ranged from 2 weeks to 36 months (median, 16 months). Eighty-four (83%) of these patients did not relapse or recur during the remainder of the duration of the study, whereas 19 did ( Fig. 1 ). There were 36 hospitalizations for recurrent osteomyelitis among 28 individual patients; the original episodes for 9 of these recurrences had been diagnosed at another facility before their arrival at our hospital. There were no significant differences in median age, sex, theater of operation, site of osteomyelitis, or overall use of orthopedic devices between initial episode of osteomyelitis and episodes of recurrent osteomyelitis. External fixators were more commonly present during original episodes, and internal fixations more common at the time of recurrence. There was no difference in ISS between patients who did and did not have recurrent infections (median for no recurrence, 9 [range, and recurrence, 9 [range, ). There was also no difference in intensive care unit days between patients with or without recurrences (median for no Bacteria associated with original episodes of osteomyelitis were also compared with recurrent episodes, with recurrent episodes significantly different in terms of microbiology (Table 2) . Overall, cultures of bone and deep wound taken during original episodes were much more likely to grow gram-negative rods ( p Ͻ 0.01). In particular, Abc, Klebsiella pneumoniae, and Pseudomonas aeruginosa each were significantly more likely to be isolated during an original episode than at recurrence ( p Ͻ 0.01, 0.04, and Ͻ0.01, respectively). In contrast, gram-positive cocci were significantly more likely to be cultured during recurrences of osteomyelitis ( p Ͻ 0.01). This was true for S. aureus in general, methicillin susceptible S. aureus (MSSA), methicillin resistant S. aureus (MRSA), and coagulase-negative staphylococci ( p Ͻ 0.01 for each). Infections were also significantly more likely to be polymicrobial (numerous pathogens recovered during culture) during the original episode ( p Ͻ 0.01). The clinical courses for each of the 19 patients whose data for both the original episode and recurrence was available are reported in Table 3 . The documented duration of antimicrobial therapy with a single agent ranged from 10 days to 150 days; 90% of patients received greater than 4 weeks of therapy with any given antibiotic, and 78% received greater than 6 weeks of therapy. The antimicrobial agent or duration of therapy was not significantly associated with likelihood of recurrent infection, nor was the organism originally recovered from culture. Notably, all but one of the original episodes received therapy that would have been expected to cover MSSA (including antistaphylococcal and broad-spectrum penicillins, cephalosporins, vancomycin, and carbapenems). In a subset analysis, after removal of those originally infected with methicillin-resistant staphylococci, 67% of those ultimately recurring with MRSA (n ϭ 6) received Ͼ2 weeks of vancomycin up front, compared with 13% of those not recurring with MRSA (n ϭ 82, p Ͻ 0.01).
Outcomes of initial and subsequent hospitalizations for osteomyelitis were not significantly different, although there was a trend toward more amputations during original episodes of osteomyelitis (27 vs. 17%, p ϭ 0.08). There were no deaths in either group. Among those original episodes that ultimately recurred or relapsed, the median time to first relapse was 128 days (range, 30 -387 days).
DISCUSSION
As the mortality rate of combat-related wounds has decreased during recent conflicts, large numbers of injured service members have survived to sustain infectious complications of their wounds. Most of these infections have involved MDR-GNR including Abc, which was first reported in injured service members returning from Iraq and Afghanistan in 2003. 8 Since that time, it has been the predominant organism recovered in trauma-related infections in this demographic, most of which have been wound infections. Given the association of poor bone healing and delayed union with underlying fracture in the setting of wound infection, 15 many clinicians at our institution opt to treat these as osteomyelitis, and use longer courses of parenteral therapy.
Early on in our collective experience with these infections, there was considerable concern about subsequent treatment failures and long-term outcomes in treating osteomyelitis and deep seated wound infections in these patients, given the typical necessity of retention of hardware and the presence of extensively antibiotic resistant pathogens. These data provide some reassurance that the majority (84 of 103 of our original episodes reviewed) do not require readmission and further therapy for osteomyelitis, although it is possible that some recurrences were treated at other facilities or were not captured by our review given the short follow-up of some casualties. More interesting is the limited role that the majority of MDR-GNR seemingly have among recurrences, being eclipsed by the emergence of staphylococci, as has also been reported in the setting of combatassociated tibia fractures. 14 These data are useful for prognostic purposes, especially when considering extension of a potentially toxic parenteral regimen in the hope of preventing recurrent osteomyelitis.
The remarkable occurrence of gram-positive bacteria recovered at recurrence of osteomyelitis and not the initial gram-negative organisms begs the question whether grampositive bacteria were present initially at the time of injury or associated with nosocomial transmission during hospital care. Cultures taken from US service members at the time of initial injury, and again within 72 hours thereafter, have revealed predominantly staphylococci, and very few MDR-GNR in wounds. 16, 17 Nosocomial transmission of Abc among injured service members has been supported by recent molecular data. 18 It is possible that overgrowth of gram-negative organisms at the time of debridement causes those gram-positives to be missed. Studies evaluating whether detection of grampositive organisms improves with use of selective media are planned. However, it is unlikely that staphylococci would be missed by overgrowth of gram-negatives on multiple cultures, and the majority of the individuals had multiple procedures with deep wound cultures obtained for each. Additionally, all but one of the casualties received antibiotics that would be expected to cover MSSA during their original treatment course, and the use of any antimicrobial agent (including vancomycin) was not found to significantly contribute to the likelihood of recurrence. In fact, casualties that received more than 2 weeks of vancomycin at the time of initial treatment, but did not have wound culture evidence of a methicillin-resistant Staphylococcus spp. during their original episode of osteomyelitis, were actually more likely to recur with MRSA on subset analysis. The most plausible explanation for this is that these patients were known to be colonized with MRSA at sites other than their wound, and thus were treated "prophylactically" with vancomycin. The fact that these patients were more likely to recur with MRSA despite use of vancomycin argues against this agent's prolonged use as preventive therapy for patients colonized, but not obviously infected with MRSA. These data taken together suggest that the staphylococci responsible for relapse are likely nosocomially introduced at some point after the original injury into an open wound or during a surgical procedure, either from the patient's own preexisting skin flora or acquired in the hospital. With regard to risk factors for recurrence of osteomyelitis, the only variable that was statistically significant was the presence of an orthopedic device; foreign bodies in general have been well established as risk factors for recurrence of osteomyelitis. It is possible that other risk factors in this population would have been identified, were the sample size larger. Other risk factors that have been described in the civilian population include vascular insufficiency, diabetes, P. aeruginosa as a causative pathogen, and use of vancomycin instead of a ␤-lactam antibiotic for gram-positive infections. Additionally, in children with contiguous osteomyelitis after trauma, the presence of Staphylococcus aureus, antibiotic-resistant bacteria, fixation of a long bone and compound fractures impact likelihood of recurrence, as does adequacy of initial antimicrobials. 11, 19 Our data have several limitations. The diagnosis of osteomyelitis was captured by querying an electronic database for the diagnosis given by a physician, and did not require proof by histologic examination of bone; some cases undoubtedly involved an infected wound overlying fractured bone, but without established infection in the bone. However, given the clinical difficulties inherent in establishing an absolute diagnosis of osteomyelitis, this likely strengthens the applicability of these data to a clinical population. The number of original episodes captured that eventually relapsed was small, and it is possible that for this reason statistically significant risk factors for relapse were undetectable. We also were unable to evaluate the number of surgical procedures performed and the ISS for each patient, which may have contributed to recurrence or relapse. Additionally, some of those classified as "recurrences" were likely primary treatment failures. However, the long median duration of follow-up before first relapse argues against this for the majority, and clinically would represent a significant adverse outcome with similar predictors and risk factors.
In summary, there were significant differences in microbiology between original and subsequent admissions for osteomyelitis. Although MDR-GNR including Abc prevailed early, these were largely eradicated by the original course of therapy, despite such limitations as drug resistance and retention of components. However, staphylococci, including MRSA, emerged as causative organisms in more than half the recurrences, likely representing reinfection. These data have significance for future efforts into microbiologic diagnostics and infection control, as well as empiric therapy of those injured service members with recurrences of osteomyelitis.
